Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/6/2025

Treatment of E. coli Infections with Ertapenem

Considerations for E. coli Producing Extended-Spectrum Beta-Lactamases (ESBL)

  • Ertapenem is the preferred carbapenem for ESBL-producing E. coli infections due to its once-daily administration and the need to reserve other carbapenems for severe infections 1, 2
  • For bacteremia without septic shock caused by ESBL-producing E. coli, ertapenem may be preferred over imipenem or meropenem (conditional recommendation, moderate certainty of evidence) 1

Precautions and Special Considerations

  • Caution is advised in patients with suspected immediate hypersensitivity to beta-lactams 1, 2
  • From an antimicrobial stewardship perspective, the use of carbapenems should be limited if alternative options are available 1, 2
  • For non-severe ESBL-producing E. coli infections, alternatives such as piperacillin/tazobactam or trimethoprim-sulfamethoxazole (if susceptibility is confirmed) should be considered 1